[Updated on Apr. 18] Integration of CiNii Articles into CiNii Research

Treatment of renal cell carcinoma with systemic administration of intermediate doses of recombinant human interleukin-2 alone. Recombinant Human Interleukin-2 (S-6820) Research Group on Renal Cell Carcinoma

Journal

Related Articles

See more

Details

  • CRID
    1370851343941248640
  • Data Source
    • Crossref
Back to top